Latest news with #InfluxHealthtechLtd
News18
14 hours ago
- Business
- News18
Influx Healthtech IPO Allotment: A Step-By-Step Guide To Check Status Online Today, Know Latest GMP
Last Updated: According to market observers, the GMP of the Influx Healthtech IPO is 22.92%, indicating decent listing gains for investors. Influx Healthtech IPO Allotment: The initial public offering of Influx Healthtech has received a whopping 201.35 times subscription, indicating huge interest from investors. Investors are now eagerly awaiting its allotment even its latest GMP shows a strong 22.92% listing gains. The allotment of the Influx Healthtech IPO is expected to be finalised today, Monday, June 23, in the evening. Once the IPO allotment is finalised, investors will start receiving bank debit messages, most probably in the evening. They can also check their allotment status on the websites of the NSE as well as registrar Maashitla Securities Private Limited. The allotment is expected to be finalised in the evening today, Friday, June 20. The allotment status can be checked by following these steps: Step 1: Visit Maashitla Securities' portal — Step 2: Under 'Select Company', choose 'Influx Healthtech Ltd'. Importantly, if the company's name is not visible in the drop-down list, it means the allotment has not been finalised yet. According to market observers, the GMP of the Influx Healthtech IPO is 22.92%, indicating decent listing gains for investors. The GMP is based on market sentiments and keeps changing. 'Grey market premium' indicates investors' readiness to pay more than the issue price. Influx Healthtech IPO Listing Date The shares of Influx Healthtech Ltd will be listed on the NSE Emerge on June 25. The Influx Healthtech IPO was open for subscription between June 18 and June 20. It is a book-built issue worth Rs 58.57 crore, comprising a fresh issue of 50 lakh equity shares worth Rs 48 crore and an offer for sale of 11 lakh shares aggregating to Rs 10.56 crore. On the final day of bidding on Friday, the SME IPO received an overwhelming 201.35 times subscription, garnering bids for 81,71,71,200 shares as against 40,58,400 shares on offer. The retail and NII participation stood at 117.68 times and 481.10 times, respectively. Its qualified institutional buyer (QIB) category got a 137.87 times subscription. The price of the Influx Healthtech IPO was fixed at Rs 96 apiece. Influx Healthtech Ltd's revenue increased 5% and its profit after tax (PAT) rose 19% between the financial year ending with March 31, 2025, and March 31, 2024. Rarever Financial Advisors Pvt Ltd is the book-running lead manager of the Influx Healthtech IPO, while Maashitla Securities Private Limited is the registrar for the issue. The market maker for Influx Healthtech IPO is R K Stock Holding Private Limited. Influx Healthtech Ltd, founded in September 2020, is a healthcare-focused CDMO with three manufacturing units in Thane, producing tablets, capsules, powders, liquid orals, and softgels.
News18
3 days ago
- Business
- News18
Influx Healthtech IPO Receives Over 201.3x Subscription On Final Day Of Bidding; Check GMP Today
The GMP of the Influx Healthtech IPO is 18.75%, indicating strong listing gains for investors. Influx Healthtech IPO Day 3: The initial public offering of Influx Healthtech Ltd has been closed today, Friday, June 20. The IPO has received a strong response from investors. Till 5:00 pm on the final day of bidding on Friday, the Rs 55.63-crore SME IPO received an overwhelming 201.35 times subscription, garnering bids for 81,71,71,200 shares as against 40,58,400 shares on offer. The retail and NII participation stood at 117.68 times and 481.10 times, respectively. Its qualified institutional buyer (QIB) category got a 137.87 times subscription. The three-day IPO was opened on Wednesday, June 18. It received a 5.89 times subscription on Day 1 on Wednesday and a 25.47 times subscription on Day 2. Influx Healthtech IPO Price The price of the Influx Healthtech IPO has been fixed at Rs 96 apiece. Influx Healthtech IPO Lot Size The minimum lot size is 1,200 shares, requiring a retail investment of Rs 1,15,200. For NIIs, the minimum is 2 lots (2,400 shares) at Rs 2,30,400. According to market observers, the GMP of the Influx Healthtech IPO is 18.75%, indicating strong listing gains for investors. The 18.75% GMP is significantly lower than the 39.58% premium recording in the morning. The GMP is based on market sentiments and keeps changing. 'Grey market premium' indicates investors' readiness to pay more than the issue price. The shares of Influx Healthtech Ltd will be listed on the NSE SME on June 25. The Eppeltone Engineers IPO is a book-built issue worth Rs 55.63 crore, comprising a fresh issue of 46.94 lakh equity shares worth Rs 45.07 crore and an offer for sale of 11 lakh shares aggregating to Rs 10.56 crore. The IPO opened for subscription on June 18, 2025, and will close on June 20, 2025. Share allotment is likely to be finalised on June 23, with the listing expected on the NSE SME platform on June 25, 2025. The price band is set at Rs 96 per share. Influx Healthtech Ltd's revenue increased 5% and its profit after tax (PAT) rose 19% between the financial year ending with March 31, 2025, and March 31, 2024. Rarever Financial Advisors Pvt Ltd is the book-running lead manager of the Influx Healthtech IPO, while Maashitla Securities Private Limited is the registrar for the issue. The market maker for Influx Healthtech IPO is R K Stock Holding Private Limited. Influx Healthtech Ltd, founded in September 2020, is a healthcare-focused CDMO with three manufacturing units in Thane, producing tablets, capsules, powders, liquid orals, and softgels.
News18
5 days ago
- Business
- News18
Influx Healthtech IPO GMP Today: Check Subscription Status On Day 2 Of Bidding
Last Updated: The GMP of the Influx Healthtech IPO is 46.88%, indicating strong listing gains for investors. Influx Healthtech IPO Day 2: The initial public offering of Influx Healthtech Ltd witnessing the second day of bidding on Thursday, June 19. The IPO has received a decent response from investors. Till 11:10 am on the second day of bidding on Thursday, the Rs 55.63-crore SME IPO received a 9.51 times subscription, garnering bids for 3,85,99,200 shares as against 40,58,400 shares on offer. The retail and NII participation stood at 14.03 times and 9.69 times, respectively. Its qualified institutional buyer (QIB) category got a 1.46 times subscription. The three-day IPO was opened on Wednesday, June 18, and will be closed on Friday, June 20. It received a 5.89 times subscription on Day 1 on Wednesday. Influx Healthtech IPO Price The price of the Influx Healthtech IPO has been fixed at Rs 96 apiece. Influx Healthtech IPO Lot Size The minimum lot size is 1,200 shares, requiring a retail investment of Rs 1,15,200. For NIIs, the minimum is 2 lots (2,400 shares) at Rs 2,30,400. Influx Healthtech IPO GMP Today According to market observers, the GMP of the Influx Healthtech IPO is 46.88%, indicating strong listing gains for investors. The shares of Influx Healthtech Ltd will be listed on the NSE SME on June 25. The GMP is based on market sentiments and keeps changing. 'Grey market premium' indicates investors' readiness to pay more than the issue price. The Eppeltone Engineers IPO is a book-built issue worth Rs 55.63 crore, comprising a fresh issue of 46.94 lakh equity shares worth Rs 45.07 crore and an offer for sale of 11 lakh shares aggregating to Rs 10.56 crore. The IPO opened for subscription on June 18, 2025, and will close on June 20, 2025. Share allotment is likely to be finalised on June 23, with the listing expected on the NSE SME platform on June 25, 2025. The price band is set at Rs 96 per share. Influx Healthtech Ltd's revenue increased 5% and its profit after tax (PAT) rose 19% between the financial year ending with March 31, 2025, and March 31, 2024. Rarever Financial Advisors Pvt Ltd is the book-running lead manager of the Influx Healthtech IPO, while Maashitla Securities Private Limited is the registrar for the issue. The market maker for Influx Healthtech IPO is R K Stock Holding Private Limited. Influx Healthtech Ltd, founded in September 2020, is a healthcare-focused CDMO with three manufacturing units in Thane, producing tablets, capsules, powders, liquid orals, and softgels.
